Ahmed bin Saeed honours the winner of the first Aster Guardians Global Nursing Award 2022
Published on May 12, 2022
FY22 Revenue of ₹10,660 Mn; growth of 31.46% YoY
FY22 Profit After Tax at ₹1,522 Mn; growth of 116.48%
Anupam Rasayan India Ltd. (BSE- 543275, NSE- ANURAS, ISIN: INE930P01018), one of India’s leading custom synthesis and specialty chemical player, has announced its financial results for the quarter and year ended March 31, 2022.
Financial Highlights for Quarter Ended March 31st, 2022:
Financial Highlights for Twelve Months Ended March 31st, 2022:
Anand Desai, Managing Director of Anupam Rasayan, commented, “I am pleased to announce that we have delivered a robust year registering a total revenue growth of 29%, mostly driven by a healthy volume ramp-up. With new LOIs getting signed and older ones getting converted into long-term contracts, the visibility for topline growth in the years to come becomes clearer.”
“Further, our foray into Fluorination chemistries, which will drive our next phase of growth has been strengthened by our successful acquisition of Tanfac’s 26% stake. By the means of this acquisition, we look forward to backward integrate our supply chains in this vertical and focus on production of high value -high margin molecules that have application in varied industries which will give us impetus to enhance our margin profile.”